JPMorgan Chase & Co. Reiterates “€27.00” Price Target for Evonik Industries (EVK)

JPMorgan Chase & Co. set a €27.00 ($31.40) price target on Evonik Industries (FRA:EVK) in a research report report published on Tuesday. The firm currently has a sell rating on the stock.

Several other research analysts have also recently issued reports on EVK. Sanford C. Bernstein set a €36.00 ($41.86) target price on shares of Evonik Industries and gave the stock a buy rating in a report on Tuesday. UBS Group set a €29.00 ($33.72) price target on shares of Evonik Industries and gave the company a sell rating in a report on Tuesday. Commerzbank set a €39.00 ($45.35) price target on shares of Evonik Industries and gave the company a buy rating in a report on Wednesday, July 11th. Baader Bank set a €40.00 ($46.51) price target on shares of Evonik Industries and gave the company a buy rating in a report on Tuesday. Finally, Warburg Research set a €38.00 ($44.19) price target on shares of Evonik Industries and gave the company a buy rating in a report on Wednesday, July 18th. Five analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of €34.48 ($40.09).

Shares of Evonik Industries stock opened at €26.51 ($30.83) on Tuesday. Evonik Industries has a 1 year low of €26.78 ($31.14) and a 1 year high of €32.97 ($38.34).

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

See Also: Can individual investors take part in an IPO?

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply